107.519 articles found

Cocreating a Mobile Health App Providing Physical Activity Recommendations for Older People Living With Parkinson Disease or Dementia: User-Centered Pilot Study

Bentlage E, del Río Ponce A, Ahmed M, Gangas P, Brach M, Kurano J, Menéndez J.

JMIR formative research · 2025-01-01

SUN-040 A α-synuclein Mouse Model Of Parkinson Disease For Studying Fsh Effects

Check source for author details

Journal of the Endocrine Society · 2025-01-01

Effect of saffron supplementation on Parkinson’s disease: a study protocol for a triple-blind randomised controlled clinical trial

Hajhashemy Z, Khorvash F, Bagherniya M, Askari G.

BMJ open · 2025-01-01

Dopaminergic Drugs and Valproate-associated Refractory Hyponatremia Over Levosulpiride-induced Parkinsonism in an Elderly Female Patient When Deprescribing was the Only Therapy.

Dehade A, Chakrabarti SS, Reddy NTS, Kaur U.

Curr Drug Saf · 2025-01-01

DOI: 10.2174/0115748863288106240313042127PMID: 38523545

Single-Cell Nuclear Sequencing Atlas Revealed the Induction of Parkinson's Disease by RELN+ Neuron 3 and the Gene Regulatory Network of MSRA.

Liu Y, Wu Y.

Curr Med Chem · 2025-01-01

DOI: 10.2174/0109298673289286240322041842PMID: 38561620

Unraveling the Ties: Type 2 Diabetes and Parkinson's Disease - A Nano-Based Targeted Drug Delivery Approach.

De S, Banerjee S, Rakshit P, Banerjee S, Kumar SKA.

Curr Diabetes Rev · 2025-01-01

DOI: 10.2174/0115733998291968240429111357PMID: 38747222

A Review of the Protective Effects of Alkaloids against Alpha-synuclein Toxicity in Parkinson's Disease.

Khodadadi M, Javadi B.

Mini Rev Med Chem · 2025-01-01

DOI: 10.2174/0113895575306884240604065754PMID: 38874050

The Smart Drug Delivery of Rotigotine Using Transdermal Patch for the Successful Management of Parkinson's Disease.

Dharmian JP, PushpaNathan ACS, Ramakrishnan P, Subramanian RN, Levy JD, Palani P, Krishnaswami V.

Cent Nerv Syst Agents Med Chem · 2025-01-01

DOI: 10.2174/0118715249289689240607064642PMID: 38910418

Interplay between subthalamic nucleus and spinal cord controls parkinsonian nociceptive disorders.

Charles KA, Molpeceres Sierra E, Bouali-Benazzouz R, Tibar H, Oudaha K, Naudet F, Duveau A, Fossat P, Benazzouz A.

Brain · 2025-01-01

DOI: 10.1093/brain/awae200PMID: 38916480

A Review on Therapeutic Strategies against Parkinson's Disease: Current Trends and Future Perspectives.

Papagiouvannis G, Theodosis-Nobelos P, Rekka EA.

Mini Rev Med Chem · 2025-01-01

DOI: 10.2174/0113895575303788240606054620PMID: 38918988

The Neuro-Healing Frontier: Alpha-Mangostin's Potential in Alzheimer's and Parkinson's Treatment.

Goyal A, Agrawal N, Agrawal N, Verma A, Solanki K, Yadav HN.

Comb Chem High Throughput Screen · 2025-01-01

DOI: 10.2174/0113862073311357240626103752PMID: 38984574

Impact of Stimulation Frequency on Verbal Fluency Following Bilateral Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease.

Busteed L, García-Sánchez C, Pascual-Sedano B, Grunden N, Gironell A, Kulisevsky J, Pagonabarraga J.

Arch Clin Neuropsychol · 2025-01-01

DOI: 10.1093/arclin/acae062PMID: 39127889